University of Dundee

School of Research

Short Code: 
SoR

Appointment strengthens ties with pharma industry

A University of Dundee researcher is to join an international collaboration that brings scientists from academia together with one of the world’s largest pharma companies to help develop new drugs for cancer and other devastating diseases.

Doreen Cantrell, Professor of Cellular Immunology at the University’s School of Life Sciences, has been selected to join GSK’s Immunology Network, a programme designed to embed academic scientists in GSK laboratories with the goal to broaden scientific insight and drive major breakthroughs in applied immunology.

Hari Hundal appointed Academic Regional Lead for South Asia

Professor Hari Hundal has been appointed as Academic Regional Lead (ARL) for South Asia. International recruitment is a key strategic priority for the University, and Professor Hundal’s personal knowledge of the region and his dedication to the student experience make him an excellent appointee.

Professor Hundal is also acting as Race Equality Charter (REC) Lead and has completed a significant amount of work in this area. He will continue to progress in this role.

Accreditation awarded by Royal Society of Biology for BSc Honours degree programmes for further 5 years

The twelve major BSc Honours degree programmes offered by the University of Dundee in Biological and Biomedical Sciences have been awarded accreditation by the Royal Society of Biology for a further five years.  These programmes are Biochemistry, Biological Chemistry and Drug Discovery, Biological Sciences (including with specialisms), Molecular Biology, Molecular Genetics, Microbiology, Biomedical Sciences, Neuroscience, Pharmacology, and Physiological Sciences. Re-accreditation follows an independent and rigorous review by the Society.

Major funding award to further new male contraceptive research

University of Dundee research that aims to develop a new male contraceptive has been boosted by major new funding from the Bill & Melinda Gates Foundation.

Experts will utilise the $1.7 million award over the next two years to continue their quest to identify suitable compounds with the potential to develop the first safe and effective male contraceptive drug.

Repair of mitochondrial recycling defect linked to Parkinson’s disease

Treating mice that have a Parkinson’s disease-causing mutation with a small molecule compound restores the removal of damaged mitochondria from their brain cells, shows a study published today in eLife.

The findings may help explain what goes wrong in dopamine-producing brain cells in people with mutations that cause Parkinson’s disease.

Parkinson’s disease is caused by the progressive loss of brain cells that produce dopamine. This causes the hallmark symptoms of the disease, including tremors, rigid movements, sleep problems and dementia.

Pages